Fresenius Medical Care AG Debt-to-Equity Ratio Growth & History (FME)
Fresenius Medical Care AG's debt-to-equity ratio was 0.81 for fiscal 2025.
View full Fresenius Medical Care AG company overviewFresenius Medical Care AG annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.81 | 0.06 | +7.59% |
| 2024 | 2024-12-31 | 0.75 | −0.14 | −15.75% |
| 2023 | 2023-12-31 | 0.89 | −0.05 | −5.12% |
| 2022 | 2022-12-31 | 0.94 | −0.11 | −10.10% |
| 2021 | 2021-12-31 | 1.05 | −0.05 | −4.98% |
| 2020 | 2020-12-31 | 1.10 | −0.43 | −28.12% |
| 2019 | 2019-12-31 | 1.54 | 0.89 | +139.30% |
| 2018 | 2018-12-31 | 0.64 | −0.04 | −5.63% |
| 2017 | 2017-12-31 | 0.68 | −0.08 | −10.21% |
| 2016 | 2016-12-31 | 0.76 | — | — |
Fresenius Medical Care AG quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.87 | 0.32 | +58.36% |
| Q1 2026 | 2026-03-31 | 0.83 | 0.36 | +77.61% |
| Q4 2025 | 2025-12-31 | 0.81 | 0.06 | +7.59% |
| Q3 2025 | 2025-09-30 | 0.53 | −0.00 | −0.35% |
| Q2 2025 | 2025-06-30 | 0.55 | 0.02 | +4.72% |
| Q1 2025 | 2025-03-31 | 0.47 | −0.09 | −16.52% |
| Q4 2024 | 2024-12-31 | 0.75 | −0.14 | −15.75% |
| Q3 2024 | 2024-09-30 | 0.53 | −0.03 | −5.56% |
| Q2 2024 | 2024-06-30 | 0.53 | −0.06 | −9.86% |
| Q1 2024 | 2024-03-31 | 0.56 | −0.02 | −3.39% |
| Q4 2023 | 2023-12-31 | 0.89 | −0.05 | −5.12% |
| Q3 2023 | 2023-09-30 | 0.56 | −0.02 | −2.94% |
| Q2 2023 | 2023-06-30 | 0.58 | −0.03 | −5.44% |
| Q1 2023 | 2023-03-31 | 0.58 | −0.07 | −10.17% |
| Q4 2022 | 2022-12-31 | 0.94 | −0.11 | −10.10% |
| Q3 2022 | 2022-09-30 | 0.57 | −0.07 | −11.41% |
| Q2 2022 | 2022-06-30 | 0.62 | −0.06 | −8.87% |
| Q1 2022 | 2022-03-31 | 0.65 | 0.03 | +4.17% |
| Q4 2021 | 2021-12-31 | 1.05 | −0.05 | −4.98% |
| Q3 2021 | 2021-09-30 | 0.65 | −0.38 | −36.67% |
| Q2 2021 | 2021-06-30 | 0.68 | −0.30 | −30.42% |
| Q1 2021 | 2021-03-31 | 0.62 | −0.38 | −37.72% |
| Q4 2020 | 2020-12-31 | 1.10 | −0.43 | −28.12% |
| Q3 2020 · Sep 30 | 2020-09-30 | 1.02 | 0.03 | +2.97% |
| Q2 2020 | 2020-06-30 | 0.97 | 0.28 | +40.73% |
| Q1 2020 | 2020-03-31 | 1.00 | 0.35 | +54.00% |
| Q4 2019 | 2019-12-31 | 1.54 | 0.89 | +139.30% |
| Q3 2019 | 2019-09-30 | 0.99 | 0.45 | +81.86% |
| Q2 2019 | 2019-06-30 | 0.69 | 0.11 | +18.06% |
| Q1 2019 | 2019-03-31 | 0.65 | −0.02 | −3.51% |
| Q4 2018 | 2018-12-31 | 0.64 | −0.04 | −5.63% |
| Q3 2018 | 2018-09-30 | 0.55 | — | — |
| Q2 2018 | 2018-06-30 | 0.59 | — | — |
| Q1 2018 | 2018-03-31 | 0.67 | — | — |
| Q4 2017 | 2017-12-31 | 0.68 | −0.08 | −10.21% |
| Q4 2016 | 2016-12-31 | 0.76 | — | — |
Fresenius Medical Care AG debt-to-equity ratio trends
Over the last five fiscal years, Fresenius Medical Care AG's debt-to-equity ratio decreased from 1.10 to 0.81, a change of −0.29. The latest reported quarter, Q2 2026, shows 0.87.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fresenius Medical Care AG source filings ↗